| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |